American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.
Maron
Barry J
BJ
McKenna
William J
WJ
Danielson
Gordon K
GK
Kappenberger
Lukas J
LJ
Kuhn
Horst J
HJ
Seidman
Christine E
CE
Shah
Pravin M
PM
Spencer
William H
WH
Spirito
Paolo
P
Ten Cate
Folkert J
FJ
Wigle
E Douglas
ED
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000209:etiology; D001281:Atrial Fibrillation / Q000209:etiology / Q000628:therapy; D002304:Cardiac Pacing, Artificial; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D017115:Catheter Ablation; D016757:Death, Sudden, Cardiac / Q000453:epidemiology; D004359:Drug Therapy, Combination; D000431:Ethanol / Q000627:therapeutic use; D015316:Genetic Therapy; D006346:Heart Septum / Q000601:surgery; D006801:Humans; D018570:Risk Assessment; D014694:Ventricular Outflow Obstruction / Q000209:etiology / Q000503:physiopathology; D014700:Verapamil / Q000008:administration & dosage / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000431:Ethanol; D014700:Verapamil